Health ProductsType I recall

Taro-Zoledronic Acid: The affected lots may contain particulate matter

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: Taro-Zoledronic Acid
Issue: Health products - Product quality
What to do: Check your product or contact your pharmacist to determine if it is recalled. If you have a recalled product, do not use it and return it to your pharmacy for a replacement product and proper disposal. If you have used the recalled product and have health concerns, contact your healthcare provider. Go to the hospital immediately if you develop difficulty breathing, chest pain or confusion.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

LotBrandProduct NameMarket AuthorizationDosage FormStrength
JKX1910A, JKX4318A, JKX5541A, HAC2371A, HAC4421A, HAD0156ATaro-Zoledronic AcidTaro-Zoledronic AcidDIN 02415100SolutionZOLEDRONIC ACID (ZOLEDRONIC ACID MONOHYDRATE) 5 MG / 100 ML

Issue

Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter.

Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's disease (a condition that disrupts the normal cycle of bone renewal).

If particulate matter is injected into a patient, there is potential for injury, such as inflammation or irritation of the veins, infections at the site of injection or in other parts of the body, allergic reactions, and the formation of blood clots that can move to other parts of the body. In the most serious cases, blood clots could move to the lungs and cause lung damage (pulmonary embolism), which can be permanent or fatal. Patients who have been treated with a recalled drug should go to the hospital immediately if they develop difficulty breathing, chest pain or confusion.

The Department is monitoring the company's recall and will inform the public if any new health risks are identified.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime